SCTC21C Clinical Trials
3 recruitingDrug
Phase 32Phase 11
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis (NDSLCA)
Amyloidosis
Sinocelltech Ltd.90 enrolled1 locationNCT07388602
Recruiting
Phase 3
A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Multiple Myeloma (MM)
Sinocelltech Ltd.292 enrolled1 locationNCT07297329
Recruiting
Phase 1
A Clinical Study of SCTC21C in Participants With CD38+ Hematologic Malignancies
Relapsed or Refractory Hematologic Malignancies
Sinocelltech Ltd.74 enrolled1 locationNCT06252298